factory supply Fleroxacin CAS 79660-72-3 Fleroxacin powder

Fleroxacin For acute bronchitis, acute onset of chronic bronchitis and respiratory system infections such as pneumonia caused by bacteria sensitive to the product, urinary and reproductive system infections such as cystitis, nephromonnephritis, prostatitis, epididymitis, Neisseria gonorrhoeae urethritis, digestive system infections such as salmonella typhi and bacillary dysentery, etc. Skin soft tissue infection, bone infection, abdominal infection and pelvic infection.

Fleroxacin is a quinolone antibacterial drug, which is effective against gram-negative bacteria. Including Escherichia coli, Bacillus pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumonalis, Neisseria gonorrhoea and so on have strong antibacterial effects. It also has moderate antibacterial effect on gram-positive coccus such as Staphylococcus and hemolytic streptococcus. The mechanism of action of this product is to inhibit the bactericidal effect of bacterial DNA rotase.